TGT Stock Recent News
TGT LATEST HEADLINES
When interest rates are high, income investors may gravitate toward risk-free products and away from dividend stocks. Target's results have improved, but it still has more work to do.
TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) is pleased to announce that surface rock sampling has encountered gold with associated anomalous silver and tellurium in altered and mineralized intrusive rocks over a 1.25 km section of the 2.2 km Chris Creek target, a recently discovered gold-in-soil anomaly on its QV property. The Chris Creek target is located approximately 9 km northwest of the VG deposit and appears to be similar in character to the VG and Golden Saddle deposits which form part of the Company's flagship White Gold Project (Figure 1). The White Gold Project is located in west-central Yukon, Canada, and comprises 16 million tonnes averaging 2.23 g/t Au for 1,152,900 ounces of gold in the Indicated Resource category and 19 million tonnes averaging 1.54 g/t Au for 942,400 ounces of gold in the Inferred Resource category (1). These new results form part of the Company's 2024 exploration program on its
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - Bayhorse Silver Inc, (TSXV: BHS) (OTCQB: BHSIF) (FSE: 7KXN) (the "Company" or "Bayhorse") announces an underground diamond drill program to drill the large low-resistivity anomaly that extends from beneath the Company's silver/copper rich Bayhorse Silver Mine in Oregon, USA, and extends northward for over 5,000 ft (1.5km) to the north, to test for the presence of a porphyry copper deposit. Figure 1. Resistivity data from survey by Geotech Ltd's proprietary VTEM system.
LYB's electricity consumption constitutes approximately 15% of its 2020 baseline scope 1 and 2 greenhouse gas emissions.
- Target Hospitality Board Disbands Special Committee - - Target Hospitality to Reinvigorate Focus on Allocating Capital to High Return Initiatives, Including In-Organic Growth - - Reaffirms 2024 Outlook Given Strength of Year-to-Date Operating Results - THE WOODLANDS, Texas , Sept. 25, 2024 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality," "Target" or the "Company") (Nasdaq: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today announced that the Company's Board of Directors has determined to disband the Special Committee of the Company's Board of Directors (the "Special Committee"), comprised solely of independent directors, which it had established to consider and evaluate the previously announced unsolicited non-binding offer, received on March 24, 2024, from Arrow Holdings S.
Target's multi-category assortment of owned and exclusive brands and popular national brands makes it a one-stop shopping destination.
Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announced it has achieved the target patient enrollment of 100 patients in "ARCHER", its Phase II randomized, double-blind, placebo-controlled trial evaluating the impact of CardiolRx™ on myocardial recovery in patients with acute myocarditis. "We are pleased to have achieved our target patient enrollment in the ARCHER trial, which reflects the commitment and dedication of our clinical collaborators and participating patients.
Constellation Energy received price target increases Monday after its deal with Microsoft.
- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months –
MYT Netherlands' strategy, focusing on unique experiences for high-end shoppers, should continue to drive robust growth. MYTE's 4Q24 results show improving margins and strong US market penetration, with US revenue growing 25% y/y. The valuation is attractive, trading at ~7.7x forward EBITDA, with the potential for higher multiples given the improving growth and margin outlook.